DMAC2L and Disorder of energy metabolism: We have previously reported that notoginsenoside NR1 can reduce the energy metabolism disorder caused by I/R by inhibiting the ROCK pathway and increasing the level of mitochondrial ATP synthase subunit, which at least partially protects I/R-injured myocardial tissue (He et al., 2014).